Stock Taper 
ORBIMED ADVISORS LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 ACADIA Pharmaceuticals Inc. | ACAD | 137K | $3.47M |
 Axsome Therapeutics, Inc. | AXSM | 117.58K | $28.78M |
 Dianthus Therapeutics, Inc. | DNTH | 115K | $11.21M |
 Elevance Health Inc. | ELV | 114.7K | $44.36M |
 Tyra Biosciences, Inc. | TYRA | 102K | $3.26M |
 argenx SE | ARGX | 92.88K | $86.17M |
 Thermo Fisher Scientific Inc. | TMO | 90.7K | $45.47M |
 Krystal Biotech, Inc. | KRYS | 83.2K | $30.92M |
 Rapport Therapeutics, Inc. Common Stock | RAPP | 76.62K | $3.19M |
 West Pharmaceutical Services, Inc. | WST | 70.6K | $25.35M |
 Revolution Medicines, Inc. | RVMD | 70.5K | $13.2M |
 Biogen Inc. | BIIB | 61.6K | $13.31M |
 PTC Therapeutics, Inc. | PTCT | 49.1K | $4.01M |
 Protagonist Therapeutics, Inc. | PTGX | 42.1K | $5.16M |
 Waters Corporation | WAT | 40.3K | $15.11M |
 Tarsus Pharmaceuticals, Inc. | TARS | 35.58K | $2.24M |
 Cytokinetics, Incorporated | CYTK | 25.8K | $2.2M |
 Alnylam Pharmaceuticals, Inc. | ALNY | 17K | $5.12M |